- Home
- PRPO vs MIRA Comparison
PRPO vs MIRA Comparison
Compare PRPO & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- MIRA
- Stock Information
- Founded
- PRPO N/A
- MIRA 2020
- Country
- PRPO United States
- MIRA United States
- Employees
- PRPO 57
- MIRA N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- PRPO Industrials
- MIRA Health Care
- Exchange
- PRPO Nasdaq
- MIRA Nasdaq
- Market Cap
- PRPO 9.5M
- MIRA 17.1M
- IPO Year
- PRPO N/A
- MIRA 2023
- Fundamental
- Price
- PRPO $6.59
- MIRA $1.05
- Analyst Decision
- PRPO
- MIRA Strong Buy
- Analyst Count
- PRPO 0
- MIRA 2
- Target Price
- PRPO N/A
- MIRA $14.00
- AVG Volume (30 Days)
- PRPO 7.9K
- MIRA 552.1K
- Earning Date
- PRPO 11-11-2024
- MIRA 11-11-2024
- Dividend Yield
- PRPO N/A
- MIRA N/A
- EPS Growth
- PRPO N/A
- MIRA N/A
- EPS
- PRPO N/A
- MIRA N/A
- Revenue
- PRPO $16,719,999.00
- MIRA N/A
- Revenue This Year
- PRPO $75.18
- MIRA N/A
- Revenue Next Year
- PRPO N/A
- MIRA N/A
- P/E Ratio
- PRPO N/A
- MIRA N/A
- Revenue Growth
- PRPO 52.61
- MIRA N/A
- 52 Week Low
- PRPO $4.31
- MIRA $0.51
- 52 Week High
- PRPO $8.99
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- PRPO 52.82
- MIRA 38.97
- Support Level
- PRPO $6.42
- MIRA $1.04
- Resistance Level
- PRPO $6.99
- MIRA $1.20
- Average True Range (ATR)
- PRPO 0.33
- MIRA 0.07
- MACD
- PRPO -0.04
- MIRA 0.02
- Stochastic Oscillator
- PRPO 69.91
- MIRA 19.44
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.